Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Kickfund is a venture capital firm based in Switzerland, established to support technology ventures recognized by the Venture Kick competition. Backed by the Ernst Göhner and Gebert Rüf Foundations, it aims to position Switzerland as a global hub for innovation and entrepreneurship. The firm focuses on creating a diversified portfolio of high-growth companies in the deep-tech sector.
Kickfund invests in promising technology startups in Switzerland, particularly in the deep-tech sector, with a check size of up to CHF 850,000. Their systematic investment strategy emphasizes co-investment in leading ventures, aiming to provide resources and support to help these startups scale effectively.
Notable portfolio companies include ASTRA Therapeutics AG, focused on drug development for parasitic diseases; ATLyphe AG, which develops targeted immunotherapy for cancer; AzureCell SA, a spin-off from the University of Geneva working on regenerative cell therapies; Abologix Sàrl, developing monoclonal antibody therapeutics; and Abrinca GmbH, addressing data analysis in microbial genomics.
Submit your pitch through their form at kickfund.ch or email your deck to wanja@kickfund.ch.
Kickfund typically co-invests alongside other investors, focusing on leading ventures in the deep-tech sector.
Kickfund is open to follow-on investments, particularly for companies that demonstrate significant growth potential and align with their investment thesis.
Kickfund's investment strategy allows for co-investments of up to CHF 850,000, but specific fund size details are not disclosed.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.